Skip to content

On this page

Zinplava

bezlotoxumab

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Zinplava

Proper name

bezlotoxumab

Licence type

351(a)

BLA number

761046

Applicant

Merck Sharp & Dohme LLC

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
1,000MG/40ML (25MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	October 21, 2016

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity